Lo. Dragsted et al., BIOACTIVATION OF 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]-PYRIDINE BY LIVER-MICROSOMES FROM 3 DIFFERENT RAT STRAINS, Pharmacology & toxicology, 72(6), 1993, pp. 388-393
The biotransformation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyrid
ine (PhIP) and the protein binding of PhIP and 2-amino-3-methylimidazo
[4,5-f]quinoline (IQ) was studied using microsomes from PCB-pretreated
or untreated male rats of the strains, Wistar, Fischer and Sprague-Da
wley. The microsomal monooxygenases, P450IA1 and IA2, which are import
ant for the biotransformation of heterocyclic amines, were quantified
by immunoblots. The two metabolites detected, -methyl-6-(4'-hydroxyphe
nyl)imidazo[4,5-b]pyridine (4'OH-PhIP) and droxyamino-1-methyl-6-pheny
limidazo[4,5-b]pyridine (N2-OH-PhIP) were formed in similar amounts wh
ereas no minor metabolites were found in our highly sensitive radioche
mical assay. Irrespective of the rat strain used, pretreatment with PC
B significantly induced both the activation and the detoxication in al
l three rat strains. Except for a significantly higher concentration o
f P450IA2 in microsomes from control and PCB induced Wistar rats, no m
ajor differences between the strains were found.